Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cat Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending…
WuXi Biologics Achieves “CDMO of the Year” Among Three Prestigious IMAPAC Awards WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has received the “CDMO of the Year – Asia Pacific”, “Best Biologics…
QIAGEN Secures CE-IVDR Certification for Full QIAstat-Dx Portfolio, Expands Diagnostic Leadership with Enhanced Meningitis/Encephalitis Panel QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced a significant regulatory milestone: the company has secured CE-IVDR certification for its entire QIAstat-Dx syndromic…
Avanzanite Bioscience Strengthens Leadership with Appointment of Dr. Mark Bechter as Senior Vice President of Medical Affairs Avanzanite Bioscience B.V., a rapidly expanding European specialty pharmaceutical company dedicated to improving the lives of patients with rare diseases, announced today the…
Nuvig Therapeutics Strengthens Leadership Team with Appointment of David J. Woodhouse, Ph.D., as Chief Executive Officer and James Mackay, Ph.D., as Independent Board Chair Nuvig Therapeutics, Inc. (“Nuvig”), a privately held biotechnology company dedicated to developing transformative immunomodulatory therapeutics for…
Evonik and Ethris Forge Strategic Alliance to Redefine Nucleic Acid Delivery with Novel Lipid Nanoparticle Platform In a move that underscores the rapid evolution of nucleic acid-based medicines and the growing importance of advanced drug delivery technologies, Evonik, a global…
Alnylam Pharmaceuticals Launches $500 Million Convertible Senior Notes Offering to Strengthen Strategic Flexibility and Advance RNAi Pipeline Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the biotechnology pioneer recognized worldwide as the leader in RNA interference (RNAi) therapeutics, has announced the commencement of…
Amazon Pharmacy Expands $5 RxPass Subscription Service to Texas, Offering Affordable Medication Access for Millions Amazon Pharmacy, the digital healthcare arm of Amazon, announced today that it is expanding RxPass, its flat-fee monthly prescription service, to Texas. This move marks…
Aptar Pharma and Dianosic Forge Exclusive Partnership to Advance Resorbable Intranasal Scaffold Technology for Chronic Rhinitis, Sinusitis, and Beyond In a strategic move that underscores the growing importance of patient-centric intranasal drug delivery platforms, Aptar Pharma, a global leader in…
WHO Expands Essential Medicines Lists to Include Landmark Treatments for Cancer, Diabetes, and Other Major Disease The World Health Organization (WHO) has announced a major update to its Model Lists of Essential Medicines (EML) and the Essential Medicines for Children…
Gilead Partners With PEPFAR and Global Fund to Deliver Twice-Yearly Lenacapavir for HIV Prevention Across Low- and Lower-Middle-Income Countries Gilead Sciences, Inc. (Nasdaq: GILD) has announced a major new global partnership with the U.S. State Department, the United States President’s…
MRM Health Secures €55 Million Series B Financing to Accelerate Development of Best-in-Class Microbiome-Based Biotherapeutics MRM Health NV, a pioneering clinical-stage biopharmaceutical company developing transformative microbiome-based therapeutics, announced the successful closing of a €55 million (approximately US$64 million) Series B…